Tassie L. Collins

NGM Biopharmaceuticals (United States) — United States

Medicine · Health Sciences

25h-index2.1kcitations44works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chemokine receptors and signaling(13), Immunotherapy and Immune Responses(9), T-cell and B-cell Immunology(7), Immune Cell Function and Interaction(7), Neurogenesis and neuroplasticity mechanisms(5)

Publications44 total

Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions
BMC Research Notes·2016· 12 citedOpen Access
A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells
BMC Research Notes·2016· 63 citedOpen Access
Development of a central nervous system axonal myelination assay for high throughput screening
BMC Neuroscience·2016· 27 citedOpen Access
MOESM2 of A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells
Figshare·2016Open Access
MOESM3 of Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions
Figshare·2016Open Access
MOESM12 of Development of a central nervous system axonal myelination assay for high throughput screening
Figshare·2016Open Access
MOESM3 of A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells
Figshare·2016Open Access
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic
Nature Communications·2015· 112 citedOpen Access
Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging
Multiple Sclerosis Journal·2015· 20 citedOpen Access
Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD2 receptors CRTH2 and DP
Bioorganic & Medicinal Chemistry Letters·2014· 4 citedOpen Access
Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists
Bioorganic & Medicinal Chemistry Letters·2011· 5 citedOpen Access
Discovery of potent and specific CXCR3 antagonists
Bioorganic & Medicinal Chemistry Letters·2011· 20 citedOpen Access
Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism
Bioorganic & Medicinal Chemistry Letters·2011· 8 citedOpen Access
Discovery of AMG 853, a CRTH2 and DP Dual Antagonist
ACS Medicinal Chemistry Letters·2011· 33 citedOpen Access
Discovery and optimization of CRTH2 and DP dual antagonists
Bioorganic & Medicinal Chemistry Letters·2009· 26 citedOpen Access
Optimization of a series of quinazolinone-derived antagonists of CXCR3
Bioorganic & Medicinal Chemistry Letters·2009· 32 citedOpen Access
Imidazo-pyrazine derivatives as potent CXCR3 antagonists
Bioorganic & Medicinal Chemistry Letters·2009· 39 citedOpen Access
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
International Journal of Cancer·2009· 110 citedOpen Access
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
British Journal of Cancer·2009· 149 citedOpen Access
CXCR3 Antagonism Impairs the Development of Donor-Reactive, IFN-γ-Producing Effectors and Prolongs Allograft Survival
Transplantation·2009· 37 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Julio C. Medina(19), Michael G. Johnson(12), George Tonn(9), An‐Rong Li(8), Jiwen Liu(7), Zice Fu(7), Timothy J. Sullivan(7), Karen Lariosa‐Willingham(7), Elen Rosler(7), Jay S. Tung(7), Jason C. Dugas(7), Dmitri Leonoudakis(7), Timothy J. Sullivan(6), Jay Danao(6), Liusheng Zhu(4), Shichang Miao(4), Xiaoqi Chen(4), Xiaohui Du(4), Jason Duquette(4), Bryan D. Lemon(4)